Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hong-Qiu Gu

Showing results (1-10 of 78) with videos related to

Pageof 8
Sort By:
JAMA|April 5, 2022
Rivaroxaban vs Apixaban and Ischemic or Hemorrhagic Events in Patients With Atrial FibrillationHong-Qiu Gu
JAMA Internal Medicine|November 9, 2020
Prediction Models for COVID-19 Need Further ImprovementsHong-Qiu Gu, Junfeng Wang
Annals of Translational Medicine|March 17, 2020
Clinical prediction models: evaluation mattersHong-Qiu Gu, Chelsea Liu
Stroke|May 16, 2019
Letter by Gu and Liu Regarding Article, "HbA1c (Glycated Hemoglobin) Levels and Clinical Outcome Post-Mechanical Thrombectomy in Patients With Large Vessel Occlusion"Hong-Qiu Gu, Li-Ping Liu
European Journal of Anaesthesiology|January 4, 2021
Reply to: assessing risk factors of delirium and its effects on adverse outcomes in patients admitted to the ICU after craniotomyLinlin Zhang, Hong-Qiu Gu, Jian-Xin Zhou
Hypertension Research : Official Journal of the Japanese Society of Hypertension|June 15, 2019
Health-related quality of life in blood pressure control and blood lipid-lowering therapies: results from the CHIEF randomized controlled trialRuohua Yan, Hong-Qiu Gu, Wen Wang, et al.
Stroke and Vascular Neurology|January 29, 2024
Reteplase versus alteplase for acute ischaemic stroke within 4.5 hours (RAISE): rationale and design of a multicentre, prospective, randomised, open-label, blinded-endpoint, controlled phase 3 non-inferiority trialShuya Li, Hong-Qiu Gu, Hongguo Dai, et al.
Annals of Translational Medicine|October 27, 2018
%ggBaseline: a SAS macro for analyzing and reporting baseline characteristics automatically in medical researchHong-Qiu Gu, Dao-Ji Li, Chelsea Liu, et al.
Biomedical and Environmental Sciences : BES|July 15, 2017
Regional Variations in Medication Usage for Cardiovascular Diseases at the Community Level in China (PURE-China Study)Jin Gang Yang, Hong Qiu Gu, Jian Bo, et al.
International Journal of Stroke : Official Journal of the International Stroke Society|June 8, 2022
Low estimated glomerular filtration rate explains the association between hyperhomocysteinemia and in-hospital mortality among patients with ischemic stroke/transient ischemic attack or intracerebral hemorrhage: Results from the Chinese Stroke Center AllianceWei Liu, Xue-Lian Ma, Hong-Qiu Gu, et al.
Pageof 8

Showing results (1-10 of 78) with videos related to

Sort By:
Pageof 8
JAMA|April 5, 2022
Rivaroxaban vs Apixaban and Ischemic or Hemorrhagic Events in Patients With Atrial FibrillationHong-Qiu Gu
JAMA Internal Medicine|November 9, 2020
Prediction Models for COVID-19 Need Further ImprovementsHong-Qiu Gu, Junfeng Wang
Annals of Translational Medicine|March 17, 2020
Clinical prediction models: evaluation mattersHong-Qiu Gu, Chelsea Liu
Stroke|May 16, 2019
Letter by Gu and Liu Regarding Article, "HbA1c (Glycated Hemoglobin) Levels and Clinical Outcome Post-Mechanical Thrombectomy in Patients With Large Vessel Occlusion"Hong-Qiu Gu, Li-Ping Liu
European Journal of Anaesthesiology|January 4, 2021
Reply to: assessing risk factors of delirium and its effects on adverse outcomes in patients admitted to the ICU after craniotomyLinlin Zhang, Hong-Qiu Gu, Jian-Xin Zhou
Hypertension Research : Official Journal of the Japanese Society of Hypertension|June 15, 2019
Health-related quality of life in blood pressure control and blood lipid-lowering therapies: results from the CHIEF randomized controlled trialRuohua Yan, Hong-Qiu Gu, Wen Wang, et al.
Stroke and Vascular Neurology|January 29, 2024
Reteplase versus alteplase for acute ischaemic stroke within 4.5 hours (RAISE): rationale and design of a multicentre, prospective, randomised, open-label, blinded-endpoint, controlled phase 3 non-inferiority trialShuya Li, Hong-Qiu Gu, Hongguo Dai, et al.
Annals of Translational Medicine|October 27, 2018
%ggBaseline: a SAS macro for analyzing and reporting baseline characteristics automatically in medical researchHong-Qiu Gu, Dao-Ji Li, Chelsea Liu, et al.
Biomedical and Environmental Sciences : BES|July 15, 2017
Regional Variations in Medication Usage for Cardiovascular Diseases at the Community Level in China (PURE-China Study)Jin Gang Yang, Hong Qiu Gu, Jian Bo, et al.
International Journal of Stroke : Official Journal of the International Stroke Society|June 8, 2022
Low estimated glomerular filtration rate explains the association between hyperhomocysteinemia and in-hospital mortality among patients with ischemic stroke/transient ischemic attack or intracerebral hemorrhage: Results from the Chinese Stroke Center AllianceWei Liu, Xue-Lian Ma, Hong-Qiu Gu, et al.
Pageof 8